Rudisill, Aaron v. oze Logging, Inc.

Tennessee Court of Workers' Compensation Claims·Decided August 6, 2026·No. 2016-06-0683·Published

Opinion

FILED Aug 06, 2026 12:15 PM(CT) TENNESSEE COURT OF WORKERS' COMPENSATION

CLAIMS

TENNESSEE BUREAU OF WORKERS’ COMPENSATION IN THE COURT OF WORKERS’ COMPENSATION CLAIMS AT NASHVILLE

Aaron Rudisill, Docket No. 2016-06-0683 Employee,

v. Boze Logging, Inc., State File No. 86190-2015 Employer,

and Clarendon Nat’l Ins. Co., Judge Kenneth M. Switzer Carrier.

COMPENSATION ORDER GRANTING MEDICAL BENEFITS

In this post-judgment claim, Aaron Rudisill seeks an order that Boze Logging authorize stem-cell treatment under an open-medical benefits provision of a settlement agreement. Medical proof showed that the authorized treating physician referred Mr. Rudisill to a neurology specialist, which referral Boze Logging repeatedly disregarded. The Court held a compensation hearing on August 4, 2026, and now finds that Mr. Rudisill has shown by a preponderance of the evidence that the doctor made a valid referral, which Boze Logging must honor.

Facts

Mr. Rudisill injured his back and spine at work on September 29, 2014, and later underwent fusion surgery. The parties settled the claim with open medical benefits.

In late 2023, Mr. Rudisill began experiencing decreased stability and increased pain in his low back and buttocks, along with numbness and stabbing pain in his left foot. At a February 2024 authorized visit with a nurse practitioner, he was referred to a “neurological surgeon.”

Rather than offering a panel of neurosurgeons, Boze Logging sent Mr.

Rudisill to an orthopedist, the current panel-selected physician, Dr. Roy Terry.

Mr. Rudisill reported low-back and leg pain at the first visit with Dr. Terry in April 2024, as well as bowel and urinary incontinence and progressive weakness in both legs. Dr. Terry documented “significant right lower extremity weakness” and ordered diagnostic testing. An MRI revealed “myelomalacia . . . at the T12 level within the thoracic cord from prior injury.”

Over the next several months, Dr. Terry repeatedly referred Mr. Rudisill for specialized treatment. In July, Dr. Terry assessed progressive focal motor weakness, right-calf atrophy, and other chronic pain. He wrote, “We will refer the patient to Dr. [Barton] Huddleston at Vanderbilt neurology about possible myelomalacia with possible treatment plans with stem cells.” (Emphasis added). In August, and after reviewing the EMG results, Dr. Terry wrote, “we will re-send the referral for the patient to see Dr. Huddleston with Vanderbilt neurology about possible myelomalacia with possible treatment plans with stem cells.” (Emphasis added). In October, he again noted the referral to Dr. Huddleston and wrote, “REFERRAL TO DR. HUDDLESTON WAS MADE AT LAST VISIT.” (Emphasis in original).

Mr. Rudisill did not see Dr. Huddleston or receive a panel of specialists.

Notes from his next visit with Dr. Terry in January 2025 explained, “We attempted to refer the patient to physician Dr. Huddleston for possible myelomalacia with possible treatment plans with stem cells, but he does not do this procedure.” Dr. Terry continued:

We are working on finding a provider who performs this procedure. In reality I am not really looking for the procedure of stem-cell itself. I am looking for someone who would be able to [say] what kind of regeneration capacity might be able to be done for someone who [has] myelomalacia[.]

Mr. Rudisill received written information from Kellum Stem Cell Institute in March, and he later discussed the documentation at a visit with Dr. Terry in May. As the plan, Dr. Terry wrote; “Recommendation for treatment with stem cell treatment and physical therapy. This gentleman did go to two separate sites for evaluation for stem cell and feels that the Kellum stem cell facility is optimal.”

Afterward, Boze Logging requested utilization review, asking, “[I]s the requested Stem Cell treatment . . . medically necessary?” The reviewing physician

did not certify the suggested treatment on May 29, 2025, and Mr. Rudisill and Dr. Terry did not appeal.

In September, Dr. Terry repeated his “recommendation for treatment with stem-cell treatment and physical therapy.” However, at that time, the utilization review noncertification remained in effect under Tennessee Compilation Rules and Regulations 0800-02-06-.06(9)(a) (2022).

At the final visit in February 2026, Dr. Terry wrote:

The patient does have the possibility of improvement only with some type of treatment with stem cells that may help to improve his condition in his spinal cord but certainly are not guaranteed to do so. I do not find evidence of any of the normal methods of moderate medicine able to find significant benefit for him. . . . It is my opinion within a reasonable degree of medical certainty that this gentleman [is] unlikely to improve with any kind of regular medical treatment. If it is possible I believe it would be reasonable to consider an attempt at treatment with more forward types of treatment which may be able to be of benefit. This treatment may include stem cell type treatment.

Boze Logging then deposed Dr. Terry in June, at which time Dr. Terry agreed that he “recommended that he seek further recommendation on stem cell care or stem cell treatment.” Dr. Terry further agreed that stem cell treatment is not his “primary area of practice.” The following relevant exchange occurred:

Q: Now, during your treatment of Mr. Rudisill, you noted you needed someone else to opine as to some stem cells and the regeneration capacity for someone who has myelomalacia, as you were uncertain to the updates in that area?

A:` Yeah, myelomalacia. Yeah. It’s a spinal cord degeneration. And yes, I did request that some information be sent and that I’d have someone call me about what the capacities were that they felt they could accomplish with him.

Boze Logging also introduced a C-32 based on a records review by Dr. Jeffrey Hazlewood, who stated that stem-cell treatment is not reasonable or necessary.

At trial, Mr. Rudisill testified to his worsening instability and weakness. He sought an appointment with a specialist and potentially stem-cell treatment.

Findings of Fact and Conclusions of Law

Mr. Rudisill bears the burden of proof and must show by a preponderance of the evidence that he is entitled to the requested benefits. Tenn. Code Ann. § 50-6- 239(c)(6) (2025).

The Workers’ Compensation Law requires an employer to furnish “medical treatment “ordered by the attending physician . . . made reasonably necessary by accident[.]” Id. § 50-6-204(a)(1)(A). Subdivision 50-6-204(a)(3)(ii) continues that when necessary, a treating physician chosen from a panel “shall make referrals to a specialist physician[.] . . . The employer shall be deemed to have accepted the referral, unless the employer, within three (3) business days, provides the employee a panel of three (3) or more independent reputable [specialist] physicians[.]”

Regulations echo this subdivision. Tennessee Compilation Rules and Regulations 0800-02-01-.06(8) (2018) states that when “the authorized treating physician, selected by the employee from an initial panel, refers the employee for specialized care, the employer shall be deemed to have accepted the referral, unless the employer, within three (3) business days, provides a panel of three (3) or more independent reputable physicians[.]”

Under section 50-6-204(a)(3)(H), once the panel-selected physician makes a referral to a specialist, it is presumed to be medically necessary. Beech v. G4S Secure Solutions (USA), Inc., 2020 TN Wrk. Comp. App. Bd. LEXIS 71, at *9-10 (Dec. 16, 2020). Further, the Appeals Board emphasized that employers must either timely honor a direct referral or offer a panel of specialists within three business days when a panel physician makes a referral. See Rhodes v. Amazon.com, 2019 TN Wrk. Comp. App. Bd. LEXIS 24, at *14 (June 11, 2019) (“[t]he statutory scheme . . . contemplates direct referrals to specialists and provides employers the option of accepting the referrals or, instead, providing a panel of specialists[.]”).

Free access — add to your briefcase to read the full text and ask questions with AI

Rudisill, Aaron v. oze Logging, Inc., (Tenn. Super. Ct. 2026).

Rudisill, Aaron v. oze Logging, Inc. (Rudisill, Aaron v. oze Logging, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 50-6
Tennessee § 50-6
§ 50-6-239
Tennessee § 50-6-239